Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (AU:RMD) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
ResMed Inc officer Brett Sandercock is set to sell 1,000 shares of the company’s common stock, acquired through restricted stock vesting as part of compensation, with an estimated aggregate market value of $233,470. The planned sale, scheduled for October 8, 2024, follows Sandercock’s recent transactions of the same stock amount in July, August, and September, each yielding gross proceeds between $194,350 and $212,160.
For further insights into AU:RMD stock, check out TipRanks’ Stock Analysis page.